OSL.AX
Price:
$1.055
Market Cap:
$19.95M
OncoSil Medical Limited, a medical device company, focuses on the development and commercialization of localized radiation therapy for the treatment of pancreatic and distal cholangiocarcinoma in worldwide. Its lead product is OncoSil, a brachytherapy device indicated for the treatment of patients with locally advanced unresectable pancreatic cancer, in combination with gemcitabine-based chemotherapy. The company was formerly known as NeuroDiscovery Limited and changed its name to OncoSil Medical Limited in May 2013. OncoSil Medical Limited was incorporated in 2005 and is headquartered in North Sydney, Australia.
Industry
Medical - Devices
IPO Date
2005-08-15
Stock Exchange
ASX
Ticker
OSL.AX
According to OncoSil Medical Limited’s latest financial reports and current stock price. The company's current Enterprise Value is 14.91M. This represents a change of -99.50% compared to the average of 2.96B of the last 4 quarters.
The mean historical Enterprise Value of OncoSil Medical Limited over the last ten years is 16.61B. The current 14.91M Enterprise Value has changed -91.02% with respect to the historical average. Over the past ten years (40 quarters), OSL.AX's Enterprise Value was at its highest in in the December 2019 quarter at 42.88B. The Enterprise Value was at its lowest in in the January 2006 quarter at 0.
Average
16.61B
Median
15.50B
Minimum
8.07M
Maximum
44.78B
Discovering the peaks and valleys of OncoSil Medical Limited Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 159.81%
Maximum Annual Enterprise Value = 44.78B
Minimum Annual Increase = -99.82%
Minimum Annual Enterprise Value = 8.07M
| Year | Enterprise Value | Change |
|---|---|---|
| 2025 | 8.07M | -99.82% |
| 2024 | 4.43B | -18.02% |
| 2023 | 5.41B | -58.28% |
| 2022 | 12.96B | -25.20% |
| 2021 | 17.33B | -39.16% |
| 2020 | 28.49B | 106.89% |
| 2019 | 13.77B | -69.26% |
| 2018 | 44.78B | 159.81% |
| 2017 | 17.24B | -20.56% |
| 2016 | 21.70B | 61.65% |
The current Enterprise Value of OncoSil Medical Limited (OSL.AX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
3.28B
5-year avg
8.03B
10-year avg
16.61B
OncoSil Medical Limited’s Enterprise Value is less than Atomo Diagnostics Limited (23.70M), greater than Neurotech International Limited (14.81M), less than HeraMED Limited (16.15M), less than Enlitic, Inc. (0), less than Resonance Health Limited (23.13M), less than IDT Australia Limited (32.25M), less than Rhythm Biosciences Limited (23.13M), greater than TruScreen Group Limited (12.66M), greater than Immuron Limited (14.62M), less than Control Bionics Limited (24.73M),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 23.70M | $26.74M | |
| 14.81M | $17.84M | |
| 16.15M | $25.33M | |
| 0 | $20.83M | |
| 23.13M | $22.30M | |
| 32.25M | $22.34M | |
| 23.13M | $23.42M | |
| 12.66M | $11.96M | |
| 14.62M | $17.33M | |
| 24.73M | $24.89M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like OncoSil Medical Limited using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like OncoSil Medical Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is OncoSil Medical Limited's Enterprise Value?
What is the highest Enterprise Value for OncoSil Medical Limited (OSL.AX)?
What is the 3-year average Enterprise Value for OncoSil Medical Limited (OSL.AX)?
What is the 5-year average Enterprise Value for OncoSil Medical Limited (OSL.AX)?
How does the current Enterprise Value for OncoSil Medical Limited (OSL.AX) compare to its historical average?